WD-treated L-selectin-deficient mice exhibited less fat accumulation and steatosis and fewer metabolic changes with improved glucose tolerance and decreased cholesterol and triglyceride levels when compared to equally treated wild-type (WT) mice. Here, SELL is linked to steatosis.